女性整个生殖寿命期的代谢功能障碍相关脂肪性肝病及其问题 - Suppr

Suppr

超能文献

Metabolic dysfunction-associated steatotic liver disease across women's reproductive lifespan and issues.

作者信息

Meda Clara, Dolce Arianna, Della Torre Sara

机构信息

Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.

Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy.

出版信息

Clin Mol Hepatol. 2025 Jan;31(1):327-332. doi: 10.3350/cmh.2024.0419. Epub 2024 Aug 5.

DOI:10.3350/cmh.2024.0419

PMID:39098816

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11791579/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9818/11791579/ef8c7fd9fb82/cmh-2024-0419f1.jpg

相似文献

Metabolic dysfunction-associated steatotic liver disease across women's reproductive lifespan and issues.女性整个生殖寿命期的代谢功能障碍相关脂肪性肝病及其问题

Clin Mol Hepatol. 2025 Jan;31(1):327-332. doi: 10.3350/cmh.2024.0419. Epub 2024 Aug 5.

Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques.代谢功能障碍相关脂肪性肝病诊断的现代化：从肝活检到非侵入性技术的逐步转变。

Therap Adv Gastroenterol. 2024 Nov 14;17:17562848241276334. doi: 10.1177/17562848241276334. eCollection 2024.

Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: Prevalence Trends and Clinical Background in the 10 Years before the Coronavirus Disease 2019 Pandemic.日本代谢相关脂肪性肝病：2019 年冠状病毒病大流行前 10 年的流行趋势及临床背景。

Medicina (Kaunas). 2024 Aug 16;60(8):1330. doi: 10.3390/medicina60081330.

Extent to which weight loss contributes to improving metabolic dysfunction-associated and metabolic and alcohol related/associated steatotic liver disease: a study on Japanese participants undergoing health checkups.减肥对改善代谢功能障碍相关和代谢及酒精相关/合并脂肪性肝病的程度：一项对接受健康检查的日本参与者的研究。

Front Endocrinol (Lausanne). 2024 May 8;15:1392280. doi: 10.3389/fendo.2024.1392280. eCollection 2024.

Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease.低至中度饮酒与代谢功能障碍相关脂肪性肝病患者的纤维化增加有关。

J Hepatol. 2024 Dec;81(6):930-940. doi: 10.1016/j.jhep.2024.06.036. Epub 2024 Jul 4.

Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis.代谢功能障碍相关脂肪性肝病和代谢功能障碍相关脂肪性肝炎中心血管风险的降低

Curr Cardiol Rep. 2025 Jan 18;27(1):28. doi: 10.1007/s11886-024-02185-5.

Metabolic and Hepatic Profiles of Non-Obese and Obese Metabolic Dysfunction-Associated Steatotic Liver Disease in Adolescents: The Role of FibroScan Parameters,Fibroblast Growth Factor-21, and Cytokeratin-18.青少年非肥胖和肥胖代谢功能障碍相关脂肪性肝病的代谢和肝脏特征：FibroScan参数、成纤维细胞生长因子-21和细胞角蛋白-18的作用

Turk J Gastroenterol. 2025 Feb 3;36(3):152-161. doi: 10.5152/tjg.2025.24760.

Practice Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease by the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN).印度儿科学会小儿胃肠病学、肝病学和营养学分会（ISPGHAN）关于代谢功能障碍相关脂肪性肝病的实践建议。

Indian Pediatr. 2024 Oct 15;61(10):919-934. Epub 2024 Sep 13.

Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation.早期实验性代谢功能障碍相关脂肪性肝病中的认知功能障碍与全身炎症和神经炎症有关。

JHEP Rep. 2023 Dec 21;6(3):100992. doi: 10.1016/j.jhepr.2023.100992. eCollection 2024 Mar.

Impact of steatotic liver disease subtypes, sarcopenia, and fibrosis on all-cause and cause-specific mortality: a 15.7-year cohort study.脂肪性肝病亚型、肌肉减少症和肝纤维化对全因死亡率和特定病因死亡率的影响：一项15.7年的队列研究。

BMC Gastroenterol. 2025 Feb 11;25(1):75. doi: 10.1186/s12876-025-03661-0.

引用本文的文献

The Ovary-Liver Axis: Molecular Science and Epidemiology.卵巢-肝脏轴：分子科学与流行病学

Int J Mol Sci. 2025 Jul 2;26(13):6382. doi: 10.3390/ijms26136382.

本文引用的文献

Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的性别二态性。

Trends Mol Med. 2024 Dec;30(12):1126-1136. doi: 10.1016/j.molmed.2024.05.013. Epub 2024 Jun 17.

Menarche and Time to Cycle Regularity Among Individuals Born Between 1950 and 2005 in the US.美国 1950 年至 2005 年出生人群的初潮年龄与月经周期规律建立时间。

JAMA Netw Open. 2024 May 1;7(5):e2412854. doi: 10.1001/jamanetworkopen.2024.12854.

Menopause and metabolic dysfunction-associated steatotic liver disease.绝经与代谢功能紊乱相关的脂肪性肝病。

Maturitas. 2024 Aug;186:108024. doi: 10.1016/j.maturitas.2024.108024. Epub 2024 May 14.

Metabolic dysfunction-associated steatotic liver disease: Emerging risk factors for adverse pregnancy outcomes.代谢功能障碍相关脂肪性肝病：不良妊娠结局的新出现危险因素。

Clin Liver Dis (Hoboken). 2024 Feb 20;23(1):e0121. doi: 10.1097/CLD.0000000000000121. eCollection 2024 Jan-Jun.

Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome.代谢功能障碍相关脂肪性肝病与多囊卵巢综合征的关联

iScience. 2024 Jan 4;27(2):108783. doi: 10.1016/j.isci.2024.108783. eCollection 2024 Feb 16.

Age at menarche and metabolic dysfunction-associated fatty liver disease: Evidence from a large population-based epidemiological study in Southwest China.初潮年龄与代谢功能障碍相关脂肪性肝病：来自中国西南部一项大型人群流行病学研究的证据。

Prev Med. 2023 Dec;177:107776. doi: 10.1016/j.ypmed.2023.107776. Epub 2023 Nov 10.

Non-alcoholic fatty liver disease in women - Current knowledge and emerging concepts.女性非酒精性脂肪性肝病——当前认知与新观点

JHEP Rep. 2023 Jun 29;5(10):100835. doi: 10.1016/j.jhepr.2023.100835. eCollection 2023 Oct.

Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance.代谢功能障碍相关脂肪性肝病（MASLD）的内分泌方面：超越胰岛素抵抗。

J Hepatol. 2023 Dec;79(6):1524-1541. doi: 10.1016/j.jhep.2023.08.030. Epub 2023 Sep 18.

Different effects of menopausal hormone therapy on non-alcoholic fatty liver disease based on the route of estrogen administration.基于雌激素给药途径，绝经激素治疗对非酒精性脂肪性肝病的不同影响。

Sci Rep. 2023 Sep 19;13(1):15461. doi: 10.1038/s41598-023-42788-6.

Pregnancy and Metabolic-Associated Fatty Liver Disease.妊娠与代谢相关性脂肪性肝病。

Endocrinol Metab Clin North Am. 2023 Sep;52(3):521-531. doi: 10.1016/j.ecl.2023.02.005. Epub 2023 Mar 22.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验